Methods and therapeutic combinations for the treatment of obesity using sterol absorption inhibitors
AssigneeSchering Corporation
InventorsHarry R. Davis, Rudyard J. Ress, John T. Strony, Enrico P. Veltri
Life of this patent
Estimating the term…
Abstract
The present invention provides methods for the treatment of obesity using sterol or 5α-stanol absorption inhibitors and compositions and therapeutic combinations including sterol or 5α-stanol absorption inhibitors and at least one obesity control medication.
Claims35
A composition comprising:
- (a) at least one obesity control medication;
- and
- (b) at least one sterol absorption inhibitor or at least one 5α-stanol absorption inhibitor or a pharmaceutically acceptable salt thereof or a solvate thereof.
A therapeutic combination comprising:
- (a) a first amount of at least one obesity control medication, and
- (b) a second amount of at least one sterol absorption inhibitor or 5α-stanol absorption inhibitor;
- wherein the first amount and the second amount together comprise a therapeutically effective amount for the treatment or prevention of obesity or lowering a concentration of a sterol or 5α-stanol in plasma of a subject.
A method of treating or preventing obesity comprising the step of administering to a subject in need of such treatment an effective amount of a composition comprising at least one sterol or 5α-stanol absorption inhibitor.
A method of treating or preventing obesity comprising the step of administering to a subject in need of such treatment an effective amount of a composition comprising at least one sterol absorption inhibitor represented by Formula (II) below:
- 96
Dependencies are inferred from the claim text.